SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001539513-12-000001
Filing Date
2012-04-27
Accepted
2012-04-27 19:24:25
Documents
1
Period of Report
2011-12-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 6072
  Complete submission text file 0001539513-12-000001.txt   7865
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1302 WAUGH DRIVE STE 618 HOUSTON TX 77019
Business Address 1302 WAUGH DRIVE STE 618 HOUSTON TX 77019 8584054448
DERMASTAR INTERNATIONAL, LLC (Reporting) CIK: 0001539513 (see all company filings)

State of Incorp.: NV | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-52998 | Film No.: 12791495